Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI

Rocket Pharmaceuticals (NASDAQ:RCKT) announced that the US Food and Drug Administration (FDA) has granted accelerated approval for KRESLADI (marnetegragene...